A short study involving one clinic visit and one PET scan, which uses Florbetapir® as an imaging agent to help determine whether or not Alzheimer’s Disease is the cause of cognitive decline.
- Male/Female age 50 or older
- Must have had symptoms of mild cognitive decline for at least 6 months
- Initial evaluation by a physician must
have occurred no more than 18 months ago